MERCK TBK PT

Company Introduction:

PT Merck Tbk is the Indonesian subsidiary of Merck KGaA, a global science and technology company headquartered in Germany. Operating in Indonesia, PT Merck Tbk focuses on three key business sectors: Healthcare, Life Science, and Electronics. The company is committed to advancing human progress by developing and manufacturing innovative pharmaceutical products, consumer health solutions, and high-quality chemicals and laboratory tools for scientific research and industrial applications. It serves patients and customers across Indonesia by providing a wide range of essential products and services.

Factory or Trader:

PT Merck Tbk functions as both a manufacturer (factory) and a trading/distribution company. The company operates manufacturing facilities in Indonesia where it produces pharmaceutical products. Concurrently, it is actively involved in the import, marketing, and distribution of a broad portfolio of pharmaceutical products, chemicals, and life science solutions sourced from its global parent company and other partners.

PT Merck Tbk in Indonesia produces or sells products primarily in two segments: Biopharma and Consumer Health.

Biopharma products include:

Medicines for fertility treatment such as Gonal-f.

Medicines for oncology (cancer treatment) such as Erbitux and Bavencio.

Medicines for metabolic disorders including Glucophage for diabetes and Euthyrox for thyroid disorders.

Medicines for cardiovascular diseases.

Medicines for neurology.

Consumer Health products include:

Vitamins and mineral supplements such as Neurobion, Sangobion, and Livron B Plex.

Over-the-counter pain relievers.

Cold and flu remedies.

Digestive health products.